New research is bringing hope to women with a hard-to-treat type of breast cancer. A study published over the weekend in the New England Journal of Medicine found that combining chemotherapy with an immunotherapy medicine added up to 10 months of survival time for patients with triple-negative breast cancer. Dr. David Agus joins "CBS This Morning" with more on the research.
